WASHINGTON -- A House sub-committee plans to hold a hearing next week to delve into how derivatives products are structured, valued, and evaluated under firms' risk management systems.
Access to authoritative analysis and perspective and our data-driven report series.
14-Day Free Trial
No credit card required. Complete access to articles, breaking news and industry data.
Have an account? Sign In